Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.

Jae-Yoon ShimMoon Young KimYoung Ju KimYoung LeeJeong Jae LeeJong Kwan JunJong Chul ShinYong Kyoon ChoKeun Young LeeJae Yoon ShimTae-Bok Song

Published in: BMC pregnancy and childbirth (2018)

FCM provided significantly greater improvements in iron parameters and QoL compared to FS in the Korean subgroup. FCM may be a preferable alternative to currently available treatments for IDA during pregnancy.

Keyphrases

iron deficiency
polycystic ovary syndrome
phase iii
pregnancy outcomes
randomized controlled trial
metabolic syndrome
breast cancer risk
study protocol